Prediction and monitoring of the response to chemoradiotherapy in oral squamous cell carcinomas using a pharmacokinetic analysis based on the dynamic contrast-enhanced MR imaging findings

Toru Chikui, Shintarou Kawano, Toshiyuki Kawazu, Masamitsu Hatakenaka, Syouzou Koga, Masahiro Ohga, Yoshio Matsuo, Syunya Sunami, Tsuyoshi Sugiura, Yoshiyuki Shioyama, Makoto Obara, Kazunori Yoshiura

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objectives To evaluate whether a pharmacokinetic analysis is useful for both predicting and monitoring the response to chemoradiotherapy (CRT) in oral cancer. Methods Patients with oral squamous cell carcinoma treated with preoperative CRT and surgery were enrolled. They underwent dynamic contrast-enhanced MRI before (n=23), and after CRT (n=20). We estimated four parameters: arrival time of contrast medium (TA), exchange rate constant from the extracellular extravascular space (EES) to plasma (kep), elimination of contrast medium from the central compartment (kel) and an amplitude scaling constant (AH) using the Brix model. The histological evaluation of the effects of CRT was performed according to Ohboshi and Shimosato's classification. We analysed the correlation between the parameters and the histological evaluation. Results The pre-CRT AH between the responders and nonresponders was significantly different (P=0.046), however, the three parameters (TA, K ep, K el) were not significantly different among the groups (P=0.76, P=0.60, P=0.09). As AH decreased, the tumour response improved. The change in the AH between the pre- and post-CRT of responders was significantly higher than that of non-responders (P=0.043). Conclusion The AH, which is affected by the ratio of the EES, was an important parameter for predicting and monitoring the tumour response to CRT.

Original languageEnglish
Pages (from-to)1699-1708
Number of pages10
JournalEuropean Radiology
Volume21
Issue number8
DOIs
Publication statusPublished - Aug 1 2011

Fingerprint

Chemoradiotherapy
Squamous Cell Carcinoma
Pharmacokinetics
Extracellular Space
Contrast Media
Mouth Neoplasms
Neoplasms

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging

Cite this

Prediction and monitoring of the response to chemoradiotherapy in oral squamous cell carcinomas using a pharmacokinetic analysis based on the dynamic contrast-enhanced MR imaging findings. / Chikui, Toru; Kawano, Shintarou; Kawazu, Toshiyuki; Hatakenaka, Masamitsu; Koga, Syouzou; Ohga, Masahiro; Matsuo, Yoshio; Sunami, Syunya; Sugiura, Tsuyoshi; Shioyama, Yoshiyuki; Obara, Makoto; Yoshiura, Kazunori.

In: European Radiology, Vol. 21, No. 8, 01.08.2011, p. 1699-1708.

Research output: Contribution to journalArticle

Chikui, Toru ; Kawano, Shintarou ; Kawazu, Toshiyuki ; Hatakenaka, Masamitsu ; Koga, Syouzou ; Ohga, Masahiro ; Matsuo, Yoshio ; Sunami, Syunya ; Sugiura, Tsuyoshi ; Shioyama, Yoshiyuki ; Obara, Makoto ; Yoshiura, Kazunori. / Prediction and monitoring of the response to chemoradiotherapy in oral squamous cell carcinomas using a pharmacokinetic analysis based on the dynamic contrast-enhanced MR imaging findings. In: European Radiology. 2011 ; Vol. 21, No. 8. pp. 1699-1708.
@article{b8ac7ad72e574ffc898ec1fb21755375,
title = "Prediction and monitoring of the response to chemoradiotherapy in oral squamous cell carcinomas using a pharmacokinetic analysis based on the dynamic contrast-enhanced MR imaging findings",
abstract = "Objectives To evaluate whether a pharmacokinetic analysis is useful for both predicting and monitoring the response to chemoradiotherapy (CRT) in oral cancer. Methods Patients with oral squamous cell carcinoma treated with preoperative CRT and surgery were enrolled. They underwent dynamic contrast-enhanced MRI before (n=23), and after CRT (n=20). We estimated four parameters: arrival time of contrast medium (TA), exchange rate constant from the extracellular extravascular space (EES) to plasma (kep), elimination of contrast medium from the central compartment (kel) and an amplitude scaling constant (AH) using the Brix model. The histological evaluation of the effects of CRT was performed according to Ohboshi and Shimosato's classification. We analysed the correlation between the parameters and the histological evaluation. Results The pre-CRT AH between the responders and nonresponders was significantly different (P=0.046), however, the three parameters (TA, K ep, K el) were not significantly different among the groups (P=0.76, P=0.60, P=0.09). As AH decreased, the tumour response improved. The change in the AH between the pre- and post-CRT of responders was significantly higher than that of non-responders (P=0.043). Conclusion The AH, which is affected by the ratio of the EES, was an important parameter for predicting and monitoring the tumour response to CRT.",
author = "Toru Chikui and Shintarou Kawano and Toshiyuki Kawazu and Masamitsu Hatakenaka and Syouzou Koga and Masahiro Ohga and Yoshio Matsuo and Syunya Sunami and Tsuyoshi Sugiura and Yoshiyuki Shioyama and Makoto Obara and Kazunori Yoshiura",
year = "2011",
month = "8",
day = "1",
doi = "10.1007/s00330-011-2102-x",
language = "English",
volume = "21",
pages = "1699--1708",
journal = "European Radiology",
issn = "0938-7994",
publisher = "Springer Verlag",
number = "8",

}

TY - JOUR

T1 - Prediction and monitoring of the response to chemoradiotherapy in oral squamous cell carcinomas using a pharmacokinetic analysis based on the dynamic contrast-enhanced MR imaging findings

AU - Chikui, Toru

AU - Kawano, Shintarou

AU - Kawazu, Toshiyuki

AU - Hatakenaka, Masamitsu

AU - Koga, Syouzou

AU - Ohga, Masahiro

AU - Matsuo, Yoshio

AU - Sunami, Syunya

AU - Sugiura, Tsuyoshi

AU - Shioyama, Yoshiyuki

AU - Obara, Makoto

AU - Yoshiura, Kazunori

PY - 2011/8/1

Y1 - 2011/8/1

N2 - Objectives To evaluate whether a pharmacokinetic analysis is useful for both predicting and monitoring the response to chemoradiotherapy (CRT) in oral cancer. Methods Patients with oral squamous cell carcinoma treated with preoperative CRT and surgery were enrolled. They underwent dynamic contrast-enhanced MRI before (n=23), and after CRT (n=20). We estimated four parameters: arrival time of contrast medium (TA), exchange rate constant from the extracellular extravascular space (EES) to plasma (kep), elimination of contrast medium from the central compartment (kel) and an amplitude scaling constant (AH) using the Brix model. The histological evaluation of the effects of CRT was performed according to Ohboshi and Shimosato's classification. We analysed the correlation between the parameters and the histological evaluation. Results The pre-CRT AH between the responders and nonresponders was significantly different (P=0.046), however, the three parameters (TA, K ep, K el) were not significantly different among the groups (P=0.76, P=0.60, P=0.09). As AH decreased, the tumour response improved. The change in the AH between the pre- and post-CRT of responders was significantly higher than that of non-responders (P=0.043). Conclusion The AH, which is affected by the ratio of the EES, was an important parameter for predicting and monitoring the tumour response to CRT.

AB - Objectives To evaluate whether a pharmacokinetic analysis is useful for both predicting and monitoring the response to chemoradiotherapy (CRT) in oral cancer. Methods Patients with oral squamous cell carcinoma treated with preoperative CRT and surgery were enrolled. They underwent dynamic contrast-enhanced MRI before (n=23), and after CRT (n=20). We estimated four parameters: arrival time of contrast medium (TA), exchange rate constant from the extracellular extravascular space (EES) to plasma (kep), elimination of contrast medium from the central compartment (kel) and an amplitude scaling constant (AH) using the Brix model. The histological evaluation of the effects of CRT was performed according to Ohboshi and Shimosato's classification. We analysed the correlation between the parameters and the histological evaluation. Results The pre-CRT AH between the responders and nonresponders was significantly different (P=0.046), however, the three parameters (TA, K ep, K el) were not significantly different among the groups (P=0.76, P=0.60, P=0.09). As AH decreased, the tumour response improved. The change in the AH between the pre- and post-CRT of responders was significantly higher than that of non-responders (P=0.043). Conclusion The AH, which is affected by the ratio of the EES, was an important parameter for predicting and monitoring the tumour response to CRT.

UR - http://www.scopus.com/inward/record.url?scp=80052679676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052679676&partnerID=8YFLogxK

U2 - 10.1007/s00330-011-2102-x

DO - 10.1007/s00330-011-2102-x

M3 - Article

VL - 21

SP - 1699

EP - 1708

JO - European Radiology

JF - European Radiology

SN - 0938-7994

IS - 8

ER -